Biolog Device Co., Ltd.

KOSDAQ:A208710 Stock Report

Market Cap: ₩47.3b

Biolog Device Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Hwang Hoon

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.8yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

Further Upside For Biolog Device Co., Ltd. (KOSDAQ:208710) Shares Could Introduce Price Risks After 49% Bounce

Jan 03
Further Upside For Biolog Device Co., Ltd. (KOSDAQ:208710) Shares Could Introduce Price Risks After 49% Bounce

Biolog Device Co., Ltd. (KOSDAQ:208710) Might Not Be As Mispriced As It Looks

Nov 14
Biolog Device Co., Ltd. (KOSDAQ:208710) Might Not Be As Mispriced As It Looks

It's Down 26% But Biolog Device Co., Ltd. (KOSDAQ:208710) Could Be Riskier Than It Looks

Jul 04
It's Down 26% But Biolog Device Co., Ltd. (KOSDAQ:208710) Could Be Riskier Than It Looks

Does Biolog Device (KOSDAQ:208710) Have A Healthy Balance Sheet?

May 21
Does Biolog Device (KOSDAQ:208710) Have A Healthy Balance Sheet?

We Think Biolog Device (KOSDAQ:208710) Has A Fair Chunk Of Debt

Mar 29
We Think Biolog Device (KOSDAQ:208710) Has A Fair Chunk Of Debt

Biolog Device (KOSDAQ:208710) Has A Somewhat Strained Balance Sheet

Nov 25
Biolog Device (KOSDAQ:208710) Has A Somewhat Strained Balance Sheet

CEO

Hwang Hoon

3.8yrs

Tenure

Hwang Hoon is Chief Executive Officer at Biolog Device Co., Ltd. since April 2021.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 15:40
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biolog Device Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution